The industry is devoting all its resources to finding a vaccine, but we should not be complacent about the need to invest in future innovation, says Bernard Mallee

Relentless innovation can future-fit Cork’s strong biopharma hub, writes Bernard Mallee

The State’s pricing deal with the pharmaceutical industry ends this year, and the funding of innovation must become a priority, if patients here are to have the early access that patients elsewhere in western Europe have, says Bernard Mallee

We lag behind other European countries in how quickly new medicines are made available to patients and this could be exacerbated by Brexit, says Bernard Mallee.